Page last updated: 2024-10-23

bendroflumethiazide and Ventricular Dysfunction, Left

bendroflumethiazide has been researched along with Ventricular Dysfunction, Left in 1 studies

Bendroflumethiazide: A thiazide diuretic with actions and uses similar to those of HYDROCHLOROTHIAZIDE. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)
bendroflumethiazide : A sulfonamide consisting of 7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by a trifluoromethyl group and that at position 3 is substituted by a benzyl group.

Ventricular Dysfunction, Left: A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almuntaser, I1
Mahmud, A1
Brown, A1
Murphy, R1
King, G1
Crean, P1
Feely, J1

Other Studies

1 other study available for bendroflumethiazide and Ventricular Dysfunction, Left

ArticleYear
Blood pressure control determines improvement in diastolic dysfunction in early hypertension.
    American journal of hypertension, 2009, Volume: 22, Issue:11

    Topics: Antihypertensive Agents; Bendroflumethiazide; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Fe

2009